No Picture
San Francisco Biotech Jobs

QC Scientist – 10x Genomics – San Francisco, CA

Troubleshoot unexpected complex equipment/QC method issues so testing can quickly resume. Applicants must be action driven, flexible, self-starters, creative,…From 10X Genomics – Mon, 01 Nov 2021 17:01:10 GMT – View all San Francisco, CA jobs […]

No Picture
News

Lost Women of Science Launches Podcast Series to Promote the Remarkable Women of Science You’ve Never Heard Of

SAN FRANCISCO: SAN FRANCISCO, Nov. 1, 2021 /PRNewswire/ — Journalist and author Katie Hafner, and bioethicist Amy Scharf, today announced the launch of the Lost Women of Science podcast series on November 4th, in partnership with public media organiza… […]

No Picture
News

CoNextions® Medical, Inc. Proudly Congratulates Evelyn Reed, MD and Her Coauthors from the Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Utah, Salt Lake City Utah for Winning the Joseph H. Boyes Award at the 39th Annual Adrian E. Flatt Residents and Fellows Conference During the 76th Annual Meeting of the American Society for Surgery for the Hand

SALT LAKE CITY: SALT LAKE CITY, Nov. 1, 2021 /PRNewswire/ — CoNextions Medical (www.conextionsmed.com) has a mission to revolutionize tendon repair in the extremities. As part of pursuing that mission, CoNextions Medical is committed to supporting sur… […]

No Picture
News

Antisense technology changed one devastating disease. Why hasn’t it transformed others?

The 2016 meeting of the Oligonucleotide Therapeutics Society in Montreal began with a rare mix of promise and elation. That year, the 27-year-old biotech Ionis showed that a drug, later branded Spinraza, could dramatically alter the course of spinal mu… […]

No Picture
News

Eiger BioPharmaceuticals Announces Complete Enrollment of D-LIVR, the Largest Phase 3 Study in Hepatitis Delta Virus (HDV), Investigating Lonafarnib, the Only Oral Agent in Development for HDV

PALO ALTO, Calif.: PALO ALTO, Calif., Nov. 1, 2021 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for serious rare and ul… […]